Neurosurgery dominates North American intraoperative neuromonitoring market, growing at 8.3% CAGR through 2022

Written by Megan Wood | October 18, 2017 | Print  |

The neurosurgery segment within the North American intraoperative neuromonitoring market will continue dominating through 2022, according to an Arizton Advisory & Intelligence analysis.

Here are four observations:

 

1. The neurosurgery segment is expected to grow at an 8.26 percent compound annual growth rate through 2022.

 

2. In 2016, the neural surgery sector captured more than 54 percent of the North American IONM market.

 

3. The growing popularity of IONM techniques for neural surgeries as well as the increasing number of neurological diseases among the population contribute to the neurosurgery segment's growth.

 

4. Analysts predict the number of brain and spinal cord tumors will grow within the next 10 years.

 

More articles on spine:
Dr. Brian Willis to chair LSU Health Shreveport's neurosurgery department on interim basis: 5 things to know
Are 2 spine surgeons better than 1 for deformity? 5 key findings
Dr. Frank Phillips: No. 1 concern for spine? Insurance companies dictating care

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months